Effects of carocainide (770207) on canine cardiac automaticity.
The benzofuran derivative carocainide is a new class I antiarrhythmic drug which has been shown to prevent and stop experimental ventricular arrhythmias. The effects of this drug on different types of cardiac automaticity were investigated by experimental models using "in situ" dogs' hearts. Complete A-V block was produced by local formaldehyde injection into the A-V junction. Carocainide at doses of 2.5, 5 and 7.5 mg/kg body weight i.v. produced the following effects: a significant and dose-related slowing of the idioventricular rate; a non-significant change of the sinus rate at 2.5 and 5 mg/kg b.w.; and a significant decrease of the total number of triggered ventricular beats induced by ventricular pacing during slow norepinephrine infusion. Our results suggest that carocainide could be a safe and effective drug for the treatment of ventricular arrhythmias.[1]References
- Effects of carocainide (770207) on canine cardiac automaticity. Huerta, F., Pourrias, B. Archives internationales de pharmacodynamie et de thérapie. (1984) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
